Saturday, October 29, 2016 Cincinnati, Ohio

15th Annual Psychopharmacology Update: Psychiatric Pharmacotherapies:
Controversies, Evidence and Best Practices

Sessions are scheduled for 60 minutes, with the last 15 for Q&A
Agenda is subject to change. Please check back for updates.

Saturday, October 29, 2016
8:30 am – 9:30 am Controversy I
Should Antidepressants Ever Be Used for Bipolar Depression?
Joseph F. Goldberg, MD

9:30 am – 10:30 am Controversy II
Is Lithium Preferable to an Anticonvulsant for Bipolar I Disorder?
Roger S. McIntyre, MD

10:30 am – 11:00 am Break

11:00 am – 12:00 pm Controversy III
Is Adjunctive Therapy Better than Switching for Treatment-resistant Depression?
Joseph F. Goldberg, MD

12:00 pm – 1:00 pm Controversy IV
Is adult ADHD a Variant of Bipolar Disorder or a Separate Disorder?
David Goodman, MD

1:00 pm – 1:15 pm Q&A with Faculty Panel

1:15 pm – 2:30 pm Lunch

2:30 pm – 3:30 pm Controversy V
Should Long-acting Injectable Antipsychotics Should Be Routinely Used for the First Episode of Schizophrenia?
Henry A. Nasrallah, MD

3:30 pm – 4:30 pm Controversy VI
Controversies in the Pharmacotherapy of Child and Adolescent Psychiatry
Melissa P. DelBello, MD

4:30 pm – 4:45 pm Break

4:45 pm – 5:45 pm Controversy VII
Why Use the Neurotoxic First-generation Antipsychotics Given the Many Neuropotective Properties of the Second Generation Antipsychotics?
Henry A. Nasrallah, MD

5:45 pm – 6:00 pm Q&A with Faculty Panel